Events
Speaking Engagement
Kisaco Research Pharma and Biotech Patent Litigation 2024
Related People
Related Services
On October 30, Axinn partner Matthew Murphy will speak on "The Global Application of Skinny Labeling and Second Medical Uses" at Kisaco Research's Pharma and Biotech Patent Litigation Conference, being held October 29-30.
Second medical use patents encourage innovation, while skinny labelling allows generics to compete without violating existing patents. This is a heated battleground for generics and innovators. Panelists will examine the latest case law from the U.S. and Europe and specifically discuss:
- Teva Pharmaceuticals USA, Inc. v. GlaxoSmithKline LLC;
- Amarin Pharma, Inc. v. Hikma Pharms. USA Inc;
- The influence of Novartis everolimus on the European application of second medical use claims and;
-
The application of Second Medical Use claims at the UPC.
To subscribe to our publications, click here.
